BR9611759A - Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano - Google Patents

Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano

Info

Publication number
BR9611759A
BR9611759A BR9611759-1A BR9611759A BR9611759A BR 9611759 A BR9611759 A BR 9611759A BR 9611759 A BR9611759 A BR 9611759A BR 9611759 A BR9611759 A BR 9611759A
Authority
BR
Brazil
Prior art keywords
treatment
animal
prevention
composition
antimicrobial peptide
Prior art date
Application number
BR9611759-1A
Other languages
English (en)
Inventor
Deborah A Steinberg
De Hwa Chao
David J Loury
Roger Cherng Fu
Conway C Chang
John C Fiddes
Original Assignee
Intrabiotics Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/752,853 external-priority patent/US6025326A/en
Application filed by Intrabiotics Pharmaceuticals filed Critical Intrabiotics Pharmaceuticals
Priority claimed from PCT/US1996/018845 external-priority patent/WO1997018827A1/en
Publication of BR9611759A publication Critical patent/BR9611759A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"PROCESSO PARA O TRATAMENTO OU PREVENçãO DE MUCOSITE ORAL EM UM ANIMAL, E, COMPOSIçãO PARA ADMINISTRAçãO ORAL TóPICA DE UM PEPTìDEO ANTIMICROBIANO"<D>. A presente invenção provê processos e composições apropriadas para o tratamento de mucosite oral em animais, incluindo humanos, com peptídeos antimicrobianos como peptídeos de protegrina.
BR9611759-1A 1995-11-22 1996-11-22 Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano BR9611759A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US56234695A 1995-11-22 1995-11-22
US64981196A 1996-05-17 1996-05-17
US69092196A 1996-08-01 1996-08-01
US08/752,853 US6025326A (en) 1995-07-07 1996-11-21 Compositions and methods for the prevention and treatment of oral mucositis
PCT/US1996/018845 WO1997018827A1 (en) 1995-11-22 1996-11-22 Compositions and methods for the prevention and treatment of oral mucositis

Publications (1)

Publication Number Publication Date
BR9611759A true BR9611759A (pt) 1999-12-28

Family

ID=27504828

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611759-1A BR9611759A (pt) 1995-11-22 1996-11-22 Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano

Country Status (10)

Country Link
EP (1) EP0865292A4 (pt)
JP (1) JP2000501388A (pt)
KR (1) KR19990071547A (pt)
AU (1) AU704851B2 (pt)
BR (1) BR9611759A (pt)
CA (1) CA2238429A1 (pt)
CZ (1) CZ159298A3 (pt)
HU (1) HUP9901183A3 (pt)
IL (1) IL124576A0 (pt)
PL (1) PL326924A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038665A2 (en) * 1996-04-03 1997-10-23 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2570599C (en) * 2004-06-24 2012-03-27 Idexx Laboratories, Inc. Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
JP5032003B2 (ja) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides
EP0836617A4 (en) * 1995-07-06 2000-06-28 Intrabiotics Pharmaceuticals PAREVINES AND TACHYTEGRINES

Also Published As

Publication number Publication date
CZ159298A3 (cs) 1998-12-16
KR19990071547A (ko) 1999-09-27
HUP9901183A3 (en) 1999-11-29
IL124576A0 (en) 1999-01-26
AU1162997A (en) 1997-06-11
PL326924A1 (en) 1998-11-09
HUP9901183A2 (hu) 1999-07-28
CA2238429A1 (en) 1997-05-29
AU704851B2 (en) 1999-05-06
EP0865292A4 (en) 2002-01-02
EP0865292A1 (en) 1998-09-23
JP2000501388A (ja) 2000-02-08

Similar Documents

Publication Publication Date Title
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
IL122248A (en) Use of nisin in the manufacture of a medicament for the treatment of an infection and pharmaceutical compositions comprising nisin for said treatment
BR9507758A (pt) Fração de copolímero-1 e composição para o tratamento de esclerose múltipla
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
CA2158058A1 (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
BR9904150A (pt) Composições de proteìnas estabilizadas
IL128270A0 (en) Pesticidal composition and method of use
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR0014740A (pt) Lantibiótico
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
BR9611759A (pt) Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano
ATE285786T1 (de) Säugetierabkömmliche peptide zur behandlung von mikrobiellen infektionen
BR9810433A (pt) Composições anti-helmìnticas
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
BR9809457A (pt) Sais de peptìdeo de bpc com atividade organo-protetora, o processo para sua preparação e seu uso em terapia.
CA2301872A1 (en) 8a-azalides as veterinary antimicrobial agents
EA199700032A1 (ru) Дезинфицирующий состав &#34;велтолен&#34;
BR0112369A (pt) Anti-helmìnticos para evitar infecções parasitárias no homem e animal ii
BR0311596A (pt) Uso de uk114 no tratamento de leishmaniose
BR9900270A (pt) Processo de tratamento e composição para controlar, prevenir e proteger animais e seres humanos da infestação e infecção por parasitas astrópodos.
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
ES2165709T3 (es) Uso de la cepa dsm 6601 de escherichia coli para el tratamiento de diarreas en el sector veterinario.
BR9610997A (pt) Composto processos para preparar o mesmo e para preparar composições contra pestes animais ou contra fungos nocivos e composição adequada e processo para controlar pestes animais ou fungos nocivos

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law